{
  "ticker": "RLF",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02972192",
  "id": "02972192",
  "pages": 23,
  "price_sensitive": true,
  "date": "20250724",
  "time": "0906",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250724/pdf/06m2zc8x5yhp6l.pdf",
  "summary": "**Quarterly Activities Report Summary (June 2025 Quarter) \u2013 RLF AgTech Ltd (ASX: RLF)**  \n\n**Financial Highlights:**  \n- **Operating Cash Flow:** Net cash from operating activities of **$3.9M** (QoQ +254%, YoY +113%); full-year FY2025 operating cash flow **$0.8M** (up 782% YoY).  \n- **Customer Receipts:** Record **$8.9M** for the quarter (YoY +74%); full-year receipts **$26.0M** (YoY +74%).  \n- **Cash Balance:** **$6.5M** at 30 June 2025 (YoY +39%).  \n\n**Operational Highlights:**  \n- **Australia:** Launched RLF Central platform, expanded to 520+ retail stores, introduced crop-specific nutrition programs.  \n- **China:** Record quarterly cash collections (**$5.3M**, YoY +73%); 62 field trials completed.  \n- **Asia Expansion:** Partnerships in Vietnam (KONA, VINCO, YAMATO) and India (trials with Gujarat Pesticides, ANU Production).  \n- **Biologicals:** Exclusive agreement with AXIOMA for biostimulant distribution in Australia/Asia.  \n\n**Corporate:**  \n- **Debt Restructuring:** $709K reduction, deferred $532K to Dec-2025, interest waived.  \n- **Board Changes:** Liza Carpene resigned (July 2025); Ben Barlow appointed Non-Executive Chair (April 2025).  \n\n**Appendix 4C Cash Flow Summary:**  \n- **Net Operating Cash Flow:** **$3.875M** (quarter), **$0.803M** (full year).  \n- **Cash Balance:** **$6.537M** (end-quarter).  \n\n**Material Changes to Capital Structure:**  \n- **Securities Issued:** 1.2M shares for CRM fees, 16.8M shares for director fees, 35.0M options (placement).  \n- **Outstanding Securities:** 371.9M shares, 124.0M listed options, 43.1M unlisted options.  \n\n**Outlook:** Focus on scaling Australia/China operations, expanding in India/Vietnam, and integrating AXIOMA biologicals.  \n\n*No material information omitted; no trading halt or capital raising announced.*",
  "usage": {
    "prompt_tokens": 11232,
    "completion_tokens": 510,
    "total_tokens": 11742,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-23T23:14:21.066242"
}